Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcelo Matiello

Showing results (41-50 of 65) with videos related to

Pageof 7
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 27, 2022
Anti-SARS-CoV-2 monoclonal antibodies for the treatment of active COVID-19 in multiple sclerosis: An observational studyGiovanna S Manzano, Dylan R Rice, Eric C Klawiter, et al.
Interventional Neurology|May 17, 2018
Progressive Neurological Decline with Deep Bilateral Imaging Changes: A Protean Presentation of Dural Arteriovenous FistulaeRene A Colorado, Marcelo Matiello, Hyun-Sik Yang, et al.
Journal of the Neurological Sciences|February 9, 2024
Predictors of relapsing disease course following index event in myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD)Negar Molazadeh, Philippe A Bilodeau, Rebecca Salky, et al.
Journal of Neuroimmunology|June 29, 2026
Clinical features, imaging findings, and treatment outcomes of optic neuritis associated with anti-CRMP5 antibodies: a systematic reviewRafael Martins Themoteo, Yang Han Yu, Joana Laura Aihara Barbosa, et al.
Neurology|February 27, 2021
Teleneurology-Enabled Determination of Death by Neurologic Criteria After Cardiac Arrest or Severe Neurologic InjuryMarcelo Matiello, Ashby C Turner, Juan Estrada, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 5, 2024
Effectiveness of immunotherapies in relapsing myelin oligodendrocyte glycoprotein antibody-associated diseasePhilippe Antoine Bilodeau, Anastasia Vishnevetsky, Negar Molazadeh, et al.
Multiple Sclerosis and Related Disorders|July 15, 2022
Treatment outcomes of first-ever episode of severe optic neuritisKristin Galetta, Sophia Ryan, Giovanna Manzano, et al.
Archives of Neurology|September 16, 2009
Treatment of neuromyelitis optica with mycophenolate mofetil: retrospective analysis of 24 patientsAnu Jacob, Marcelo Matiello, Brian G Weinshenker, et al.
Multiple Sclerosis and Related Disorders|March 10, 2026
Relapse risk factors in double seronegative neuromyelitis optica spectrum disorder: Insights from a multicenter studyGerome Vallejos, Takahisa Mikami, Joao Vitor Mahler, et al.
Annals of Neurology|October 30, 2010
Intractable vomiting as the initial presentation of neuromyelitis opticaMetha Apiwattanakul, Bogdan F Popescu, Marcelo Matiello, et al.
Pageof 7

Showing results (41-50 of 65) with videos related to

Sort By:
Pageof 7
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 27, 2022
Anti-SARS-CoV-2 monoclonal antibodies for the treatment of active COVID-19 in multiple sclerosis: An observational studyGiovanna S Manzano, Dylan R Rice, Eric C Klawiter, et al.
Interventional Neurology|May 17, 2018
Progressive Neurological Decline with Deep Bilateral Imaging Changes: A Protean Presentation of Dural Arteriovenous FistulaeRene A Colorado, Marcelo Matiello, Hyun-Sik Yang, et al.
Journal of the Neurological Sciences|February 9, 2024
Predictors of relapsing disease course following index event in myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD)Negar Molazadeh, Philippe A Bilodeau, Rebecca Salky, et al.
Journal of Neuroimmunology|June 29, 2026
Clinical features, imaging findings, and treatment outcomes of optic neuritis associated with anti-CRMP5 antibodies: a systematic reviewRafael Martins Themoteo, Yang Han Yu, Joana Laura Aihara Barbosa, et al.
Neurology|February 27, 2021
Teleneurology-Enabled Determination of Death by Neurologic Criteria After Cardiac Arrest or Severe Neurologic InjuryMarcelo Matiello, Ashby C Turner, Juan Estrada, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 5, 2024
Effectiveness of immunotherapies in relapsing myelin oligodendrocyte glycoprotein antibody-associated diseasePhilippe Antoine Bilodeau, Anastasia Vishnevetsky, Negar Molazadeh, et al.
Multiple Sclerosis and Related Disorders|July 15, 2022
Treatment outcomes of first-ever episode of severe optic neuritisKristin Galetta, Sophia Ryan, Giovanna Manzano, et al.
Archives of Neurology|September 16, 2009
Treatment of neuromyelitis optica with mycophenolate mofetil: retrospective analysis of 24 patientsAnu Jacob, Marcelo Matiello, Brian G Weinshenker, et al.
Multiple Sclerosis and Related Disorders|March 10, 2026
Relapse risk factors in double seronegative neuromyelitis optica spectrum disorder: Insights from a multicenter studyGerome Vallejos, Takahisa Mikami, Joao Vitor Mahler, et al.
Annals of Neurology|October 30, 2010
Intractable vomiting as the initial presentation of neuromyelitis opticaMetha Apiwattanakul, Bogdan F Popescu, Marcelo Matiello, et al.
Pageof 7